KENGREAL is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by The Medicines Company. The primary component is Cangrelor.
| Product ID | 65293-003_e16d2568-1d43-420c-a2b4-850f85861271 |
| NDC | 65293-003 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KENGREAL |
| Generic Name | Cangrelor |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-07-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204958 |
| Labeler Name | The Medicines Company |
| Substance Name | CANGRELOR |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-07-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204958 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-07-08 |
| Marketing End Date | 2019-02-28 |
| Marketing Category | NDA |
| Application Number | NDA204958 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-07-08 |
| Marketing End Date | 2019-02-28 |
| Ingredient | Strength |
|---|---|
| CANGRELOR | 50 mg/1 |
| SPL SET ID: | fd5534d0-92c8-41bf-9eca-8259405fbfc2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10122-620 | KENGREAL | cangrelor |
| 65293-003 | KENGREAL | cangrelor |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KENGREAL 87442665 not registered Live/Pending |
Chiesi Farmaceutici S.P.A. 2017-05-09 |
![]() KENGREAL 86166110 4867615 Live/Registered |
CHIESI FARMACEUTICI S.P.A. 2014-01-15 |